Estrogen receptor pathways to AP-1

被引:676
作者
Kushner, PJ
Agard, DA
Greene, GL
Scanlan, TS
Shiau, AK
Uht, RM
Webb, P
机构
[1] Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Pharmacol, San Francisco, CA 94143 USA
[4] Univ Chicago, Ben May Inst, Chicago, IL 60637 USA
关键词
estrogen receptor; transcription factors; coactivator;
D O I
10.1016/S0960-0760(00)00108-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Estrogen receptor (ER binds to estrogen response elements in target genes and recruits a coactivator complex of CBP-p160 that mediates stimulation of transcription. ER also activates transcription at AP-1 sites that bind the Jun/Fos transcription factors, but not ER. We review the evidence regarding mechanisms whereby ER increases the activity of Jun/Fos and propose two pathways of ER action depending on the ER (alpha or beta) and on the ligand. We propose that estrogen-ER alpha complexes use their activation functions (AF-1 and AF-2) to bind to the p 160 component of the coactivator complex recruited by Jun/Fos and trigger the coactivator to a higher state of activity. We propose that selective estrogen receptor modulator (SERM) complexes with ER beta and with truncated ER alpha derivatives use their DNA binding domain to titrate histone deacetylase (HDAC)-repressor complexes away from the Jun/Fos coactivator complex, thereby allowing unfettered activity of the coactivators. Finally, we consider the possible physiological significance of ER action at AP-1 sites. (C) 2000 Published by Elsevier Science Ltd.
引用
收藏
页码:311 / 317
页数:7
相关论文
共 42 条
  • [1] Altucci L, 1996, ONCOGENE, V12, P2315
  • [2] Molecular basis of agonism and antagonism in the oestrogen receptor
    Brzozowski, AM
    Pike, ACW
    Dauter, Z
    Hubbard, RE
    Bonn, T
    Engstrom, O
    Ohman, L
    Greene, GL
    Gustafsson, JA
    Carlquist, M
    [J]. NATURE, 1997, 389 (6652) : 753 - 758
  • [3] Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
    Bunone, G
    Briand, PA
    Miksicek, RJ
    Picard, D
    [J]. EMBO JOURNAL, 1996, 15 (09) : 2174 - 2183
  • [4] DUBIK D, 1992, ONCOGENE, V7, P1587
  • [5] Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence
    Elgort, MG
    Zou, A
    Marschke, KB
    Allegretto, EA
    [J]. MOLECULAR ENDOCRINOLOGY, 1996, 10 (05) : 477 - 487
  • [6] Endoh H, 1999, MOL CELL BIOL, V19, P5363
  • [7] Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
    Feng, WJ
    Ribeiro, RCJ
    Wagner, RL
    Nguyen, H
    Apriletti, JW
    Fletterick, RJ
    Baxter, JD
    Kushner, PJ
    West, BL
    [J]. SCIENCE, 1998, 280 (5370) : 1747 - 1749
  • [8] ACTIVATION OF THE OVALBUMIN GENE BY THE ESTROGEN-RECEPTOR INVOLVES THE FOS-JUN COMPLEX
    GAUB, MP
    BELLARD, M
    SCHEUER, I
    CHAMBON, P
    SASSONECORSI, P
    [J]. CELL, 1990, 63 (06) : 1267 - 1276
  • [9] Geum DH, 1997, MOL REPROD DEV, V46, P450, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt
  • [10] 450::AID-MRD2&gt